ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,748.93
0.03%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lexeo Therapeutics Inc (LXEO)

  7. Lexeo Therapeutics Inc (LXEO) News

LXEO Lexeo Therapeutics Inc

16.63
0.58 (3.61%)
01 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Lexeo Therapeutics Inc LXEO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.58 3.61% 16.63 10:00:00
Open Price Low Price High Price Close Price Previous Close
16.01 15.85 16.80 16.63 16.05
more quote information »

Recent News

Date Time Source Heading
23/5/202407:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202407:14EDGAR2Form 144 - Report of proposed sale of securities
09/5/202421:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202421:07EDGAR2Form 8-K - Current report
09/5/202421:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202421:00GLOBELexeo Therapeutics Reports First Quarter 2024 Financial..
07/5/202421:30GLOBELexeo Therapeutics to Participate in Upcoming Investor..
22/4/202421:30GLOBELexeo Therapeutics Announces License Agreement to Accelerate..
16/4/202421:30GLOBELexeo Therapeutics Granted FDA Fast Track Designation for..
14/3/202407:22GLOBELexeo Therapeutics Announces Closing of Oversubscribed $95.0..
12/3/202407:11EDGAR2Form 8-K - Current report
12/3/202407:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/3/202400:29EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202422:42GLOBELexeo Therapeutics Reports Fourth Quarter and Full Year 2023..
11/3/202422:30GLOBELexeo Therapeutics Announces Oversubscribed $95.0 Million..
07/2/202409:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/2/202409:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202423:03EDGAR2Form 8-K - Current report
05/2/202423:00GLOBELexeo Therapeutics Strengthens Clinical Development..
03/1/202423:00GLOBELexeo Therapeutics to Present at the 42nd Annual J.P. Morgan..
18/12/202323:00GLOBELexeo Therapeutics Granted FDA Fast Track Designation and..
11/12/202323:00GLOBELexeo Therapeutics Reports Third Quarter 2023 Financial..

Your Recent History

NASDAQ
LXEO
Lexeo Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved